SafeMark is redefining the safety industry by implementing a new gold standard in name safety testing. Our primary objective is to provide healthcare clients with a simple and sequential approach to name safety testing that adheres to guidelines set forth by global governmental authorities.
Name confusion & promotional claims impact the likelihood of rejection
by global regulatory authorities.
SafeMark’s consultations proactively address regulatory considerations to minimize risk before name creation.
Traditional name safety testing
is notorious for being
cumbersome & unpredictable.
SafeMark’s Power of 3 Methodology provides a flexible step-by-step alternative for your naming needs.
1. “Medication Error Reports.” U.S. Food and Drug Administration. Web. 14 Oct. 2015.
2. “Medication Errors.” Patient Safety Network. 1 Mar. 2015. Web. 14 Oct. 2015.
3. U.S. Food and Drug Administration (2014). Guidance for Industry: Best Practices in Developing Proprietary Names for Drugs.